NFKB1 and gastric cancer: Furthermore, neutralizing TNF-α with adalimumab could reduce coculture-induced nuclear translocation of NF-κB (Fig. 3F), suggesting the involvement of TNF-α in the interaction between gastric cancer cells and CD204+ M2-like TAMs.